Cinobufagin treatment of relapsed or refractory hematological malignant tumor: 8 cases report and literatures review.

Author: Lu WANG ¹ ; Ruihua MI ² ; Xudong WEI ² ; Lin CHEN ² ; Hao AI ² ; Qingsong YIN ² ; Ping WANG ² ;
Author Information

1. Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
2. Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University
Publication Type:Case Reports
MeSH: Bufanolides; therapeutic use; Hematologic Neoplasms; drug therapy; Humans; Recurrence
From: Chinese Journal of Hematology 2015;36(11):954-956
CountryChina
Language:Chinese